LIN:NASDAQLinde plc Analysis
Data as of 2026-04-15 - not real-time
$499.65
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Linde plc is trading well above its 20‑day (≈495), 50‑day (≈488) and 200‑day (≈460) simple moving averages, confirming a sustained bullish trend. The MACD histogram remains positive (≈0.38) and the RSI sits at a neutral 54, indicating room for upside without immediate over‑extension. Support at ~473 and resistance near ~509 frame a relatively tight range, while volume has been tapering, suggesting a possible short‑term consolidation. Fundamentally, the stock appears markedly overvalued – the DCF‑derived fair value of roughly $130 is far below the current price of $500, and a trailing P/E of 34 exceeds the sector average. Nonetheless, the company delivers robust operating margins (~28%), a solid free cash flow generation (~$4.8 bn), and a dividend yield of 1.26% with a payout ratio under 45%, supporting dividend sustainability.
Analyst sentiment is upbeat: UBS and Mizuho have raised price targets to $579 and $560 respectively, maintaining buy/outperform recommendations. Revenue growth of ~5.8% and a diversified global footprint mitigate sector‑specific risks, while a low beta (~0.3) and moderate 30‑day volatility (~19%) temper market‑risk concerns. The combination of strong cash generation, dividend appeal, and positive earnings outlook supports a favorable medium‑term outlook despite the current valuation premium.
Analyst sentiment is upbeat: UBS and Mizuho have raised price targets to $579 and $560 respectively, maintaining buy/outperform recommendations. Revenue growth of ~5.8% and a diversified global footprint mitigate sector‑specific risks, while a low beta (~0.3) and moderate 30‑day volatility (~19%) temper market‑risk concerns. The combination of strong cash generation, dividend appeal, and positive earnings outlook supports a favorable medium‑term outlook despite the current valuation premium.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near resistance with bullish technicals but overvaluation
- Decreasing volume indicating possible short‑term consolidation
- Sustainable dividend supporting investor demand
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Analyst upgrades to $560‑$579 and continued buy ratings
- Strong cash flow and margin profile enabling reinvestment
- Revenue growth and diversified global exposure
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Long‑term demand for industrial gases and specialty chemicals
- Stable dividend payout with healthy payout ratio
- Low beta and moderate volatility reducing market risk
Key Metrics & Analysis
Financial Health
Revenue Growth5.80%
Profit Margin20.30%
P/E Ratio34.2
ROE17.82%
ROA7.17%
Debt/Equity70.63
P/B Ratio6.1
Op. Cash Flow$10.4B
Free Cash Flow$4.8B
Technical Analysis
TrendBullish
RSI54.1
Support$473.44
Resistance$509.23
MA 20$494.92
MA 50$488.45
MA 200$459.67
MACDBullish
VolumeDecreasing
Fear & Greed Index88.64
Valuation
Fair Value$129.54
Target Price$516.41
Upside/Downside3.35%
GradeOvervalued
TypeGrowth
Dividend Yield1.26%
Risk Assessment
Beta0.29
Volatility19.04%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.